Table 4.
Number of doses and total quantity of factor concentrates administered
| Hemophiliacs severity | Bleeding | Inhibitors | Factors concentrates | Doses | Total |
|---|---|---|---|---|---|
| 1, severe | Yes | Yes | FEIBA/rFVIIa | 3/10 | 3600 IU/450 μg |
| 2, severe | Yes | Yes | FEIBA/rFVIIa | 3/6 | 10800 IU/810 μg |
| 3, severe | Yes | Yes | FEIBA/rFVIIa | 3/5 | 5280 IU/330 μg |
| 4, severe | Yes | No | Refacto | 10 | 7800 IU |
| 5, severe | No | No | Refacto | 5 | 1050 IU |
| 6, severe | No | No | Refacto | 5 | 900 IU |
| 7, severe | No | No | Refacto | 5 | 1500 IU |
| 8, severe | No | Yes | FEIBA/rFVIIa | 3/2 | 2640 IU/66 μg |
| 9, moderate | Yes | No | Refacto | 5 | 1800 IU |
| 10, moderate | No | No | Refacto | 3 | 810 IU |
| 11, moderate | No | No | Refacto | 3 | 1440 IU |
| 12, moderate | No | No | Refacto | 3 | 1080 IU |
| 13, moderate | No | No | Refacto | 3 | 1170 IU |
| 14, moderate | No | No | Refacto | 3 | 1170 IU |
| 15, moderate | No | No | Refacto | 3 | 1270 IU |
| 16, moderate | No | No | Refacto | 3 | 1170 IU |
| 17, moderate | No | No | Recombinate | 3 | 900 IU |
| 18, mild | No | No | Recombinate | 3 | 1440 IU |
| 19, mild | No | No | Recombinate | 3 | 1170 IU |
| 20, mild | No | No | Recombinate | 3 | 1620 IU |
| 21, mild | No | No | Recombinate | 3 | 1710 IU |
| 22, mild | No | No | Recombinate | 3 | 1890 IU |
| 23, mild | No | No | Recombinate | 3 | 2070 IU |
| 24, mild | No | No | Recombinate | 3 | 2340 IU |
| 25, mild | No | No | Recombinate | 3 | 2340 IU |
| 26, mild | No | No | Recombinate | 3 | 1710 IU |